Cargando…

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review

Mostrar otras versiones (1)

[Image: see text]

Detalles Bibliográficos
Autores principales:	Iorio, Marilena V, Croce, Carlo M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452025/ https://www.ncbi.nlm.nih.gov/pubmed/28572088 http://dx.doi.org/10.15252/emmm.201707779

Ejemplares similares

MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
por: Iorio, Marilena V, et al.
Publicado: (2012)

Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review
por: Szczepanek, Joanna
Publicado: (2020)

Editorial to the Special Issue “MicroRNA Dysregulation in Tumor Occurrence, Progression and Response to Therapy”
por: Iorio, Marilena V.
Publicado: (2021)

Zinc intake, microRNA dysregulation, and esophageal cancer
por: Fong, Louise Y., et al.
Publicado: (2016)

The functional significance of microRNA-145 in prostate cancer
por: Zaman, M S, et al.
Publicado: (2011)

Transcriptome dynamics of the microRNA inhibition response
por: Wen, Jiayu, et al.
Publicado: (2016)

Corrigendum to “Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats”
por: Silveira, André C., et al.
Publicado: (2018)

A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles
por: Guo, Jing, et al.
Publicado: (2021)

The Therapeutic Potential of MicroRNAs in Cancer: Illusion or Opportunity?
por: Fortunato, Orazio, et al.
Publicado: (2020)

Human peripheral blood-derived exosomes for microRNA delivery
por: Kang, Ji-Young, et al.
Publicado: (2019)

Corrigendum to “Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis”
por: Zhang, Hui, et al.
Publicado: (2017)

MicroRNA-1258: An invasion and metastasis regulator that targets heparanase in gastric cancer
por: Shi, Jinxin, et al.
Publicado: (2021)

MicroRNA-152 suppresses cisplatin resistance in A549 cells
por: Zhao, Wenfei, et al.
Publicado: (2020)

MirGeneDB 2.0: the metazoan microRNA complement
por: Fromm, Bastian, et al.
Publicado: (2020)

Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis
por: Suzuki, Hiroshi I., et al.
Publicado: (2013)

Integrative Gene Expression Profiling Reveals That Dysregulated Triple microRNAs Confer Paclitaxel Resistance in Non-Small Cell Lung Cancer via Cotargeting MAPT [Corrigendum]
Publicado: (2020)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2018)

MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1
por: Jiang, Qian, et al.
Publicado: (2022)

[Corrigendum] MicroRNA‑23a inhibits endometrial cancer cell development by targeting SIX1
por: Li, Hong-Lin, et al.
Publicado: (2023)

Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
por: Rana, Indrajeetsinh, et al.
Publicado: (2015)

MicroRNA-181a-5p functions as an oncogene in renal cell carcinoma
por: Lai, Yulin, et al.
Publicado: (2018)

MicroRNA-144 attenuates cardiac ischemia/reperfusion injury by targeting FOXO1
por: E, Lusha, et al.
Publicado: (2020)

MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation
por: Meng, Cuida, et al.
Publicado: (2021)

Accurate transcriptome-wide prediction of microRNA targets and small interfering RNA off-targets with MIRZA-G
por: Gumienny, Rafal, et al.
Publicado: (2015)

MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma
por: Su, Zhengming, et al.
Publicado: (2020)

MicroRNA Dysregulation in Epilepsy: From Pathogenetic Involvement to Diagnostic Biomarker and Therapeutic Agent Development
por: Wang, Jialu, et al.
Publicado: (2021)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Impact of microRNA-29b on nature killer cell in T-cell acute lymphoblastic leukemia
por: Jin, Fengyan, et al.
Publicado: (2021)

Circulating extracellular vesicle-encapsulated microRNA as screening biomarkers for intraductal papillary mucinous neoplasm
por: Sato, Yuki, et al.
Publicado: (2021)

MicroRNA Dysregulation in Prostate Cancer
por: Schitcu, Vlad Horia, et al.
Publicado: (2022)

MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency
por: Fong, Louise Y., et al.
Publicado: (2016)

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
por: Sakaguchi, Takashi, et al.
Publicado: (2018)

MicroRNA-335 is downregulated in bladder cancer and inhibits cell growth, migration and invasion via targeting ROCK1
por: Wu, Deyao, et al.
Publicado: (2022)

MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer
por: Xiao, Haibing, et al.
Publicado: (2022)

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome
por: Ryan, J, et al.
Publicado: (2012)

MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2
por: Tian, Faqing, et al.
Publicado: (2019)

MicroRNA-122 ameliorates corneal allograft rejection through the downregulation of its target CPEB1
por: Wang, Ting, et al.
Publicado: (2017)

MicroRNA-183-5p promotes the proliferation, invasion and metastasis of human pancreatic adenocarcinoma cells
por: Miao, Fei, et al.
Publicado: (2021)

MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021)

Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension
por: Bertero, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e02biht5631b8oa54cfh9t80cn